Myocardial Infarction Clinical Trials
Here are the 6 most popular medical studies for myocardial infarction
SGLT2 Inhibitor
Dapagliflozin for Heart Attack Recovery
This trial will test if dapagliflozin can improve heart function and reduce enlargement after a heart attack. Participants will take the medication or a placebo once daily for six months and have follow-up MRI tests and clinic visits.
Popular filter options for myocardial infarction trials
Heart Attack Clinical Trials
View 47 Heart Attack medical studies.
Procedure
Electrophysiological Imaging for Ventricular Tachycardia
This trial is testing a new way to map and treat ventricular tachycardia, which contributes to over 350,000 sudden deaths each year in the US. The new method uses catheter ablation to "block" the channel that forms the circuit, with guidance from 3D images. The hope is that this will improve ablation efficacy and help clinicians identify ablation targets and assess ablation outcome.
Low-Dose tPA in PCI for Heart Attack
This trial will test whether using a low dose of the drug tissue plasminogen activator during primary percutaneous coronary intervention (PCI) for patients with ST elevation myocardial infarction (STEMI) can reduce the incidence of post-procedural myocardial blush (MBG) grade 0/1 or distal embolization.
Behavioral Intervention
Stress Management for Heart Attack
This trial is studying stress management in women who have had a heart attack. Women will fill out stress questionnaires and may be enrolled in the study if they report high levels of stress. They will be randomly assigned to either a stress management program or usual care, and followed for 6 months.
Coronary Artery Disease Clinical Trials
View 11 Coronary Artery Disease medical studies.
Behavioural Intervention
Virtual Cardiac Rehab Program for Heart Disease
This trial is testing whether a multi-component virtual cardiac rehabilitation program can help improve cholesterol levels, cardiovascular health, quality of life and mental health for patients recently diagnosed with atherosclerotic cardiovascular disease.
Behavioral Intervention
In-Person vs Telehealth Cardiac Rehab for Heart Disease
This trial will compare 2 methods of delivering cardiac rehab: in-person and via telehealth, to see if they have the same effects and who benefits more from one or the other.
Phase 3 Myocardial Infarction Clinical Trials
View 64 phase 3 myocardial infarction medical studies.
Low-Dose tPA in PCI for Heart Attack
This trial will test whether using a low dose of the drug tissue plasminogen activator during primary percutaneous coronary intervention (PCI) for patients with ST elevation myocardial infarction (STEMI) can reduce the incidence of post-procedural myocardial blush (MBG) grade 0/1 or distal embolization.
Physician Payment Models for Heart Conditions
This trial will compare two models for physician payment, one in which physicians are paid a fee for each service provided (fee-for-service), and one in which physicians are given a bonus for meeting quality standards (pay-for-performance). The goal is to see if the pay-for-performance model results in better care for patients with heart conditions.
Implantable Device
Implantable Cardioverter Defibrillator for Heart Attack
This trial will test whether an implantable defibrillator can help people who have had a heart attack in the last five years, have abnormal test results from a 24-hour heart monitor, and have low normal heart function.
Myocardial Infarction Clinical Trials With No Placebo
View 64 myocardial infarction medical studies that do not have a placebo group.
Procedure
Electrophysiological Imaging for Ventricular Tachycardia
This trial is testing a new way to map and treat ventricular tachycardia, which contributes to over 350,000 sudden deaths each year in the US. The new method uses catheter ablation to "block" the channel that forms the circuit, with guidance from 3D images. The hope is that this will improve ablation efficacy and help clinicians identify ablation targets and assess ablation outcome.
Behavioral Intervention
Stress Management for Heart Attack
This trial is studying stress management in women who have had a heart attack. Women will fill out stress questionnaires and may be enrolled in the study if they report high levels of stress. They will be randomly assigned to either a stress management program or usual care, and followed for 6 months.
View More Myocardial Infarction Trials
See another 39 medical studies focused on myocardial infarction.
Frequently Asked Questions
Introduction to myocardial infarction
What are the top hospitals conducting myocardial infarction research?
When it comes to cutting-edge clinical trials in the field of myocardial infarction, several top hospitals are making significant strides. The renowned Mayo Clinic, located in Rochester, has four active trials focused on this condition and a total of six completed studies. Since recording their first myocardial infarction trial in 2013, they have been at the forefront of research and innovation. Duke University Medical Center, situated in Durham, is another prominent institution that stands out with its four ongoing myocardial infarction trials and a remarkable twelve completed studies since their initial trial back in 2000.
The University of Pittsburgh Medical Center also plays a vital role in advancing our understanding of myocardial infarction. With four active clinical trials and an impressive seventeen previous studies under their belt since initiating research on this topic in 2006, they continue to contribute valuable insights into this life-threatening condition. On the west coast, Vancouver General Hospital boasts an equally notable record with four ongoing myocardial infarction trials and seventeen accomplished studies dating back to their first recorded trial in 2003.
Adding itself to this list is Reid Physician Associates based in Richmond where currently three active clinical inquiries are being taken place regarding myocardial infractions following along with completion of three similar investigations so far since only introduced such pioneering project last year during2020.
These esteemed institutions signify hope for individuals affected by heart attacks while serving as beacons for progress within the medical community at large. Their collective efforts bring us closer to breakthroughs that can improve treatment options and save lives worldwide
Which are the best cities for myocardial infarction clinical trials?
When it comes to myocardial infarction clinical trials, several cities show promise in advancing research and treatment. New york, with its 14 active trials, focuses on interventions like Liberal Transfusion Strategy, Enhanced Usual Care (EUC), and Orbital Atherectomy (OA). Edmonton, Alberta follows closely behind with 11 ongoing studies exploring strategies such as Liberal Transfusion Strategy, Implantable Cardioverter Defibrillator + Usual Care, and Restrictive Transfusion Strategy. Lastly, Atlanta, Georgia; Minneapolis, Minnesota; and Pittsburgh, Pennsylvania each have 9 active trials investigating various approaches including Young Participants with Prior MI, Blood Transfusion strategies,and In-person cardiac rehabilitation. These cities provide patients with opportunities to participate in groundbreaking clinical trials for myocardial infarction that may shape the future of care.
Which are the top treatments for myocardial infarction being explored in clinical trials?
Clinical trials are paving the way for innovative treatments to combat myocardial infarction, also known as a heart attack. The top contenders in these trials include intervention and the Ellipsis Health Voice Application. Intervention is currently being explored in two active trials and has been listed since 2005, while the Ellipsis Health Voice Application shows promise with one ongoing trial since its debut in 2022. These cutting-edge approaches hold great potential for improving outcomes and transforming the landscape of myocardial infarction management.
What are the most recent clinical trials for myocardial infarction?
Promising developments in clinical trials offer hope for individuals affected by myocardial infarction, commonly known as a heart attack. Notably, the GXT+ THHR intervention has entered its Phase 2 trial stage and holds potential for improving outcomes after experiencing a heart attack. Another significant study involves Inclisiran Sodium 300mg in Phase 3, investigating its effectiveness in reducing the risk of future cardiac events following a myocardial infarction. Furthermore, research on Hemorrhagic Myocardial Infarction - Deferiprone is currently underway during Phase 1 to explore new avenues for treatment. Lastly, Evolocumab paired with routine lipid management is being evaluated in a Phase 4 trial to assess its impact on preventing recurring heart attacks. These recent clinical trials provide optimism for enhanced care and improved quality of life among those impacted by myocardial infarctions.
What myocardial infarction clinical trials were recently completed?
Recently completed clinical trials have made significant strides in the field of myocardial infarction research. In December 2020, R-Pharm Overseas successfully wrapped up a trial investigating the potential benefits of RPH-104 80 mg for patients with this condition. The University of Arkansas concluded their study on Aspirin 81 mg in November 2018, while the University of Maryland, Baltimore finished their investigation on Clopidogrel back in August 2017. These recent advancements offer valuable insights into potential therapeutic options and contribute to our understanding and management of myocardial infarction.